Differential impact of additional chromosomal abnormalities in myeloid vs lymphoid blast phase of chronic myelogenous leukemia in the era of tyrosine kinase inhibitor therapy
Details
The content you want is available to Zendy users.Already have an account? Click here. to sign in.